Sarcopenia in solid organ transplantation

Elizabeth J. Carey

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Sarcopenia is a relatively new concept in the medical literature, initially intended to describe the loss of lean body mass that occurs with aging. More recently, sarcopenia has been described in various forms of chronic disease, including patients with end-stage organ disease awaiting transplantation. The presence of sarcopenia is an important marker in transplant patients, since it has been linked to poorer pre- and posttransplant outcomes compared with patients with preserved muscle mass. The mechanisms and natural history of sarcopenia in transplant patients are incompletely understood, and there are currently no therapies proven to mitigate or reverse the process. This article reviews the current understanding of the prevalence and clinical significance of sarcopenia in transplant patients and highlights important areas of future research.

Original languageEnglish (US)
Pages (from-to)159-170
Number of pages12
JournalNutrition in Clinical Practice
Volume29
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Sarcopenia
Organ Transplantation
Transplants
Chronic Disease
Transplantation
Muscles

Keywords

  • malnutrition
  • nutrition
  • nutrition assessment
  • organ transplantation
  • sarcopenia

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Sarcopenia in solid organ transplantation. / Carey, Elizabeth J.

In: Nutrition in Clinical Practice, Vol. 29, No. 2, 2014, p. 159-170.

Research output: Contribution to journalArticle

Carey, Elizabeth J. / Sarcopenia in solid organ transplantation. In: Nutrition in Clinical Practice. 2014 ; Vol. 29, No. 2. pp. 159-170.
@article{403a4e30ef694539acd1a63924018f8c,
title = "Sarcopenia in solid organ transplantation",
abstract = "Sarcopenia is a relatively new concept in the medical literature, initially intended to describe the loss of lean body mass that occurs with aging. More recently, sarcopenia has been described in various forms of chronic disease, including patients with end-stage organ disease awaiting transplantation. The presence of sarcopenia is an important marker in transplant patients, since it has been linked to poorer pre- and posttransplant outcomes compared with patients with preserved muscle mass. The mechanisms and natural history of sarcopenia in transplant patients are incompletely understood, and there are currently no therapies proven to mitigate or reverse the process. This article reviews the current understanding of the prevalence and clinical significance of sarcopenia in transplant patients and highlights important areas of future research.",
keywords = "malnutrition, nutrition, nutrition assessment, organ transplantation, sarcopenia",
author = "Carey, {Elizabeth J.}",
year = "2014",
doi = "10.1177/0884533613520619",
language = "English (US)",
volume = "29",
pages = "159--170",
journal = "Nutrition in Clinical Practice",
issn = "0884-5336",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Sarcopenia in solid organ transplantation

AU - Carey, Elizabeth J.

PY - 2014

Y1 - 2014

N2 - Sarcopenia is a relatively new concept in the medical literature, initially intended to describe the loss of lean body mass that occurs with aging. More recently, sarcopenia has been described in various forms of chronic disease, including patients with end-stage organ disease awaiting transplantation. The presence of sarcopenia is an important marker in transplant patients, since it has been linked to poorer pre- and posttransplant outcomes compared with patients with preserved muscle mass. The mechanisms and natural history of sarcopenia in transplant patients are incompletely understood, and there are currently no therapies proven to mitigate or reverse the process. This article reviews the current understanding of the prevalence and clinical significance of sarcopenia in transplant patients and highlights important areas of future research.

AB - Sarcopenia is a relatively new concept in the medical literature, initially intended to describe the loss of lean body mass that occurs with aging. More recently, sarcopenia has been described in various forms of chronic disease, including patients with end-stage organ disease awaiting transplantation. The presence of sarcopenia is an important marker in transplant patients, since it has been linked to poorer pre- and posttransplant outcomes compared with patients with preserved muscle mass. The mechanisms and natural history of sarcopenia in transplant patients are incompletely understood, and there are currently no therapies proven to mitigate or reverse the process. This article reviews the current understanding of the prevalence and clinical significance of sarcopenia in transplant patients and highlights important areas of future research.

KW - malnutrition

KW - nutrition

KW - nutrition assessment

KW - organ transplantation

KW - sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=84896382879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896382879&partnerID=8YFLogxK

U2 - 10.1177/0884533613520619

DO - 10.1177/0884533613520619

M3 - Article

C2 - 24531627

AN - SCOPUS:84896382879

VL - 29

SP - 159

EP - 170

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

SN - 0884-5336

IS - 2

ER -